Trial Profile
Phase II Study of Cetuximab (Erbitux) in Combination With Modified FOLFIRI in Patients With Advanced Gastric Cancer Who Failed to First-Line Chemotherapy.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 Jan 2018
Price :
$35
*
At a glance
- Drugs Cetuximab (Primary) ; Fluorouracil; Folinic acid; Irinotecan
- Indications Gastric cancer
- Focus Therapeutic Use
- Acronyms EFFI; STAGE
- 25 Dec 2009 Actual patient number (61) added as reported by ClinicalTrials.gov.
- 25 Dec 2009 Actual end date (Oct 2009) added as reported by ClinicalTrials.gov.
- 25 Dec 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.